trending Market Intelligence /marketintelligence/en/news-insights/trending/6-7ildgb_ieks8ewfzfcma2 content esgSubNav
In This List

Sol-Gel Technologies director resigns

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Sol-Gel Technologies director resigns

Yael Baratz resigned as a director of Sol-Gel Technologies Ltd. for personal reasons, effective Feb. 22.

The Israel-based pharmaceutical company appointed Yaffa Krindel to the board to replace Baratz, effective Feb. 26.

Krindel served as partner and managing partner of Star Ventures, a private venture capital fund, from 1997 until 2007. He currently serves on the board of Itamar Medical Ltd., a medical device company.